Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Neuroprotection in Alzheimer's Disease
Illana Gozes
*
(Editor)
*
Corresponding author for this work
Human Molecular Genetics Biochemistry
Research output
:
Book/Report
›
Book
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neuroprotection in Alzheimer's Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Neuroprotection
100%
Disease Management
50%
Nerve Cells
50%
Clinical Development
33%
Dementia
33%
Putting
33%
Cell Protection
33%
New Advances
33%
Cusp
16%
Novel Therapeutics
16%
Knowledge Accumulation
16%
Cognitive Ability
16%
Most Common Form
16%
Cell Degeneration
16%
Synapse
16%
State of the Field
16%
Brain Diseases
16%
Medical Doctors
16%
Brain Degeneration
16%
Basic Scientist
16%
Thinking Skills
16%
Failed Clinical Trial
16%
Medicine and Dentistry
Alzheimer's Disease
100%
Neuroprotection
100%
Disease Management
50%
Synapse
16%
Clinical Trial
16%
Brain Disease
16%
Cognitive Function
16%
Nerve Cell Degeneration
16%
Brain Degeneration
16%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Neuroprotection
100%
Diseases
50%
Cytoprotection
33%
Clinical Trial
16%
Brain Disease
16%
Nerve Cell Degeneration
16%
Brain Degeneration
16%